NCT02615600 Daily Bitemporal Low-frequency Transcranial Random Noise Stimulation in Tinnitus (tRNS2-tin)
| NCT ID | NCT02615600 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Regensburg |
| Condition | Chronic Tinnitus |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2015-11 |
| Primary Completion | 2025-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2015-11 with a primary completion date of 2025-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Stimulation of the left and right auditory cortex with daily low-frequency transcranial random noise stimulation (tRNS) is used to modulate the neural pathways involved in chronic tinnitus.
Eligibility Criteria
Inclusion criteria: * diagnosis of bothersome, subjective chronic tinnitus * diagnosis: duration of tinnitus more than 6 months Exclusion criteria: * objective tinnitus * irregular head shap below the electrodes * eczema on the head * treatable cause of the tinnitus * involvement in other treatments for tinnitus at the same time * clinically relevant psychiatric comorbidity * clinically relevant unstable internal or neurological comorbidity * history of or evidence of significant brain malformation or neoplasm, head injury * cerebral vascular events * neurodegenerative disorder affecting the brain or prior brain surgery * metal objects in and around body that can not be removed * pregnancy * alcohol or drug abuse
Contact & Investigator
Berthold Langguth
✉ berthold.langguth@medbo.deBerthold Langguth
PRINCIPAL INVESTIGATOR
University of Regensburg
Frequently Asked Questions
Who can join the NCT02615600 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Chronic Tinnitus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02615600 currently recruiting?
Yes, NCT02615600 is actively recruiting participants. Contact the research team at berthold.langguth@medbo.de for enrollment information.
Where is the NCT02615600 trial being conducted?
This trial is being conducted at Regensburg, Germany.
Who is sponsoring the NCT02615600 clinical trial?
NCT02615600 is sponsored by University of Regensburg. The principal investigator is Berthold Langguth at University of Regensburg. The trial plans to enroll 30 participants.